Please use this identifier to cite or link to this item:
Title: Experiences of caregivers of children with inherited metabolic diseases: A qualitative study
Authors: Siddiq, S
Wilson, BJ
Graham, ID
Lamoureux, M
Khangura, SD
Tingley, K
Tessier, L
Chakraborty, P
Coyle, D
Dyack, S
Gillis, J
Greenberg, C
Hayeems, RZ
Jain-Ghai, S
Kronick, JB
Laberge, A-M
Little, J
Mitchell, JJ
Prasad, C
Siriwardena, K
Sparkes, R
Speechley, KN
Stockler, S
Trakadis, Y
Wafa, S
Walia, J
Wilson, K
Yuskiv, N
Potter, BK
Keywords: Science & Technology;Life Sciences & Biomedicine;Genetics & Heredity;Medicine, Research & Experimental;Research & Experimental Medicine;Experiences with care;Inherited metabolic diseases;Family support;Coping;Qualitative research;OF-LIFE;INBORN-ERRORS;PSYCHOSOCIAL-ASPECTS;MEDICAL COMPLEXITY;PARENTAL BELIEFS;DATA SATURATION;OUTCOMES;IMPACT;DISABILITIES;DISORDERS
Issue Date: 2016
Citation: ORPHANET JOURNAL OF RARE DISEASES, 2016, 11 pp. ? - ? (10)
Abstract: Abstract Background: We sought to understand the experiences of parents/caregivers of children with inherited metabolic diseases (IMD) in order to inform strategies for supporting patients and their families. We investigated their experiences regarding the management of disease, its impact on child and family life, and interactions with the health care system. Methods: From four Canadian centres, we conducted semi-structured telephone interviews with parents/caregivers of children with an IMD who were born between 2006 and 2015 and who were participating in a larger cohort study. Participants were selected with the aim of achieving a diverse sample with respect to treatment centre, IMD, and age of the child. Interviews emphasized the impacts of the disease and its treatment on the child and family and explicitly queried perceptions of interactions with the health care system. We identified emergent themes from the interview data. Results: We completed interviews with 21 parents/caregivers. The 21 children were aged <1 to 7 years old with IMD that included amino acid disorders, urea cycle disorders, fatty acid oxidation disorders, and organic acid disorders or ‘other’ IMD. Most parents reported that they and their families had adapted well to their child’s diagnosis. Parents used proactive coping strategies to integrate complex disease management protocols into routine family life. An important source of stress was concern about the social challenges faced by their children. Participants reported positive interactions with their most involved health care providers within the metabolic clinic. However, they reported challenges associated with the health care system outside of disease-specific metabolic care, when encountering systems and providers unfamiliar with the child’s disease. Conclusions: The successful use of proactive coping strategies among parents of children with IMD in this study suggests the potential value of promoting positive coping and is an important direction for future study. Parents’ social concerns for their children were important stressors that warrant consideration by health care providers positioned to support families. Our results with respect to experiences with care highlight the important role of specialized metabolic clinics and point to a need for better coordination of the care that takes place outside the disease-specific management of IMD.
ARTN 168
ARTN 168
Appears in Collections:Dept of Clinical Sciences Research Papers

Files in This Item:
File Description SizeFormat 
Fulltext.pdf437.95 kBAdobe PDFView/Open

Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.